Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC

• Hauptverfasser: Marialucia Iacovino (Verfasst von), Vincenza Ciaramella (Verfasst von), Fernando Paragliola (Verfasst von), Gabriella Suarato (Verfasst von), Gesualdina Busiello (Verfasst von), Francesca Sparano (Verfasst von)
• Format: Buch
• Veröffentlicht: Open Exploration Publishing Inc., 2020-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Liquid biopsy has emerged as a minimally invasive alternative to tumor tissue analysis for the management of lung cancer patients, especially for epidermal growth factor receptor (EGFR) oncogene addicted tumor. In these patients, despite the clear benefits of tyrosine kinase inhibitors therapy, the...